CASP3 and myocardial infarction: Levosimendan postconditioning attenuated myocardial injury and protected the myocardium against MI-induced cardiomyocyte apoptosis by elevating mRNA and protein levels of Bcl-2 while suppressing those of Caspase-3 and Bax.